L. Silva

Druggable targets from coronaviruses for designing new antiviral drugs

S. H. Cardoso, Letícia Anderson, L. Silva, 2020, Bioorganic & Medicinal Chemistry.

Chapter 10 Challenges in designing antiviral agents

L. Silva, E. Silva-Júnior, I. Nascimento, 2023, Viral Infections and Antiviral Therapies.

Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases.

S. H. Cardoso, J. McKerrow, L. Silva, 2021, Bioorganic & medicinal chemistry.

Multi-Target Approaches of Epigallocatechin-3-O-gallate (EGCG) and its Derivatives Against Influenza Viruses.

L. Silva, E. D. da Silva-Júnior, 2022, Current Topics in Medicinal Chemistry.

Dual Quinoline-Hybrid Compounds with Antimalarial Activity Against Plasmodium falciparum Parasites

M. Meneghetti, L. Silva, L. Quintans-Júnior, 2022, New Journal of Chemistry.

A consensus reverse docking approach for identification of a competitive inhibitor of acetyltransferase enhanced intracellular survival protein from Mycobacterium tuberculosis.

V. Rodrigues-Junior, S. Garneau‐Tsodikova, L. Silva, 2024, Bioorganic & medicinal chemistry.